Z, B., G, B., T, Z., M, G., I, M., A, A., . . . A, A. (2026). Therapeutic outcomes of ²²⁵Ac/¹⁷⁷Lu-PSMA combination therapy in advanced metastatic Castration-Resistant prostate cancer: A systematic review and Meta-Analysis. European journal of nuclear medicine and molecular imaging, 53(5), 2881. https://doi.org/10.1007/s00259-025-07627-y
Chicago Style (17th ed.) CitationZ, Belabaci, Brignoli G, Zilli T, Grujić M, Mohamad I, Al-Ibraheem A, Shelan M, and Afshar-Oromieh A. "Therapeutic Outcomes of ²²⁵Ac/¹⁷⁷Lu-PSMA Combination Therapy in Advanced Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis." European Journal of Nuclear Medicine and Molecular Imaging 53, no. 5 (2026): 2881. https://doi.org/10.1007/s00259-025-07627-y.
MLA (9th ed.) CitationZ, Belabaci, et al. "Therapeutic Outcomes of ²²⁵Ac/¹⁷⁷Lu-PSMA Combination Therapy in Advanced Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis." European Journal of Nuclear Medicine and Molecular Imaging, vol. 53, no. 5, 2026, p. 2881, https://doi.org/10.1007/s00259-025-07627-y.